Quantcast

Latest Erythropoietin Stories

2010-11-10 17:30:49

Scientists are reporting development of a long-sought method with the potential for getting medication through a biological barrier that surrounds the brain, where it may limit the brain damage caused by stroke. Their approach for sneaking the nerve-protective drug erythropoietin into the brain is medicine's version of the Trojan Horse ploy straight out of ancient Greek legend. It also could help people with traumatic head injuries, Parkinson's disease, and other chronic brain disorders....

2010-11-04 12:30:00

BURLINGTON, Mass., Nov. 4, 2010 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that biosimilar erosion of branded erythropoietin stimulating agent (ESA) market share is likely to be more rapid and more complete in the United States compared to biosimilar erosion seen in Europe since biosimilar ESAs entered the European market in 2007. According to Biosimilars Advisory Service: Physician...

2010-11-01 06:00:00

DALLAS, November 1, 2010 /PRNewswire/ -- Sandler Research announces it will carry Anemia - Pipeline Assessment and Market Forecasts to 2017 Research Report in its store. Browse the complete Report on: http://www.sandlerresearch.org/reports/37162-anemia-pipeline-assessment-and-m arket-forecasts-to-2017.html Browse All Food and Beverages Reports: http://www.sandlerresearch.org/market-research/pharmaceuticals/ Search More Then 20000 Market Research Reports at...

2010-10-27 07:00:00

EXTON, Pa., Oct. 27 /PRNewswire/ -- BioTrends Research Group, Inc. released two syndicated Nephrology TreatmentTrends® publications (TreatmentTrends®: US Nephrology Q310 and TreatmentTrends®: Renal Dietitians 2010). These reports provide information gleaned from on-line surveys with 200 nephrologists and 205 renal dietitians and capture insight into attitudes, perceptions and self-reported prescribing behavior with a focus on renal...

2010-10-26 11:12:50

(Ivanhoe Newswire) -- As if high blood pressure, chronic diseases, and cancer weren't enough, high levels of erythropoietin in people over 85 join the list of silent killers. Erythropoietin is a hormone created in the kidneys to stimulate production of red blood cells. Production is triggered by impaired oxygen delivery to the kidney because of anemia or low blood oxygen levels. Studies involving patients with chronic heart failure have shown that high erythropoietin levels predict poor...

2010-10-25 16:19:37

High erythropoietin levels in people over age 85 indicate a higher risk of death, according to a study published in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj100347.pdf. Erythropoietin is a hormone created in the kidneys to stimulate production of red blood cells. Production is triggered by impaired oxygen delivery to the kidney because of anemia or low blood oxygen levels. In patients with chronic heart failure, high erythropoietin...

2010-10-18 07:03:00

THOUSAND OAKS, Calif., Oct. 18 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) will review the results from TREAT (the Trial to Reduce Cardiovascular Events with Aranesp® Therapy) and will discuss how these results inform the appropriate use of erythropoiesis-stimulating agents (ESAs) for chronic renal failure (CRF) patients at today's meeting of the Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC). "This advisory committee...

2010-10-06 09:00:00

EXTON, Pa., Oct. 6 /PRNewswire/ -- BioTrends Research Group, Inc. recently published its TreatmentTrends®: Renal Anemia in China report. This report is based on survey results from 150 nephrologists in clinical practice in China and qualitative interviews conducted with ten thought leaders in nephrology. The report examines the demographics of nephrology practice in China and focuses specifically on the management of renal anemia amongst dialysis and later stage chronic...

2010-10-05 15:57:00

THOUSAND OAKS, Calif., Oct. 5 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced that results from several important studies from the Company's oncology portfolio will be presented at the 35th European Society for Medical Oncology (ESMO) Congress, Oct. 8-12, 2010, in Milan, Italy. "Cancer is a complex disease which requires innovative therapeutic approaches. Amgen is exploring numerous biologic pathways to develop novel therapies to treat cancer and lessen the side effects of cancer...

2010-10-05 06:30:00

NES-ZIONA, Israel, Oct. 5 /PRNewswire-FirstCall/ -- PROLOR Biotech, Inc. (NYSE Amex: PBTH), a company developing next generation biobetter therapeutic proteins, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to hGH-CTP, PROLOR's longer-acting version of human growth hormone for the treatment of growth hormone deficiency. hGH-CTP is currently in a Phase II clinical trial. "By reducing the frequency of injections from as many as seven...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'kardia,' heart.
Related